Advances in Biopharmaceutical Technology in INDIA

Product Code BPA00008
Publication Date February 2008
Publisher BioPlan Associates
Product Type Book
Pages 766
ISBN Number 978-1-934106-07-5
Change currency
PDF £4,995.00 €6,015 $7,898 BUY >
PRINT £2,500 €3,011 $3,953 BUY >
CDROM £4,995 €6,015 $7,898 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Advances in Biopharmaceutical Technology in INDIA

Advances in Biopharmaceutical Technology in INDIA January 2008, ISBN 978-1-934106-07-5 780 pages; This volume provides an overview of the biopharmaceutical industry, and the state of technology in INDIA. It provides a ready reference for all aspects of biopharmaceuticals.

Contents

  • Part One: Introduction
    • Introduction: Biotechnology in India, Dr. P. K. Ghosh President-Biotechnology Cadila Pharmaceuticals Ltd
  • Part Two: The State of India Bipharmaceutical Industry
    • A Window intIndia's Biopharmaceutical Sector, N. Kulkarni, Biospectrum Asia
    • Indian Biopharmaceutical System and Policies, Yennapu Madhavi, Ph. D, Scientist, National Institute of Science Technology and Development Studies
    • Government Support for Biotech and Biopharmaceutical Industry, Dr. B. M. Gandhi, CEO, NeBioMed Services
    • Biopharmaceutical Products in India, Dr. Scott Wheelwight, Dr. Hazel Aranha, President, Strategic Manufacturing Worldwide, Inc.
    • Biogeneric Manufacturing in India, Dr. Ashesh Kumar, General Manager M J Biopharm Pvt. Ltd.
    • Biopharmaceutical Market Situation, Dr. Merlin Goldman President, Magnetical, U.K.
    • Contract Research Industry in India, Dr. Umakanta Saho& Dr. Faiz Kermani, Managing Director, Chiltern International Private Ltd.
    • Regulatory Landscape for Clinical Trials in India, Dr. Romi Singh, Executive Director, Global Regulatory Affairs, Amgen Inc.
    • Life Sciences Education in India, Dr. Dipti Sawant Dr. Umakanta Sahoo, Chiltern International Private Ltd.
  • Part Three: Scientific Issues
    • Vaccines Industry in India, Dr. PS Kulkarni Dr. SS Jadhav, Deputy Medical Director /Executive Director, Serum Institute of India Ltd
    • Development of plasma-derived biopharmaceuticals in India: issues and opportunities, Dr. John Curling, President, John Curling, Consulting AB
    • Bioprocess Technology in India, Dr. David Mousdale, Managing Director Beocarta Ltd., U.K
    • Potential Applications of Recent Advances in Immunology tDevelop Novel Therapeutic Products in India, Dr. Kumar Shah, President, Endocrine Technology, LLC
    • Early Stage Key R&D for Successful Developmetn of Protein Products, K. Madduri, Ph.D Dow AgroSciences LLC
    • Understanding Ayurveda Medicine, Dr. Sampada Mahajan, Chiltern International Private Ltd.
  • Part Four: Biobusiness in India
    • Biopharmaceutical Outsourcing: A comparative Overview of the Landscape in India and China, Minna Damani Editor, CanBiotch
    • Biopharmaceutical Research Collaboration between Western and Indian Life Science Organizations, Dr. Steve Ferguson, Director, Dr. Uri Reichman, Dr. Bharat Khurana, NIH Office of Technology Transfer
    • Outsourcing R&D tIndia, Sajai Singh, Probir Roy J. Sagar Associates
    • Venture Capital Financing, Sajai Singh Probir Roy Chodhur J. Sagar Associates
    • India Briefs
    • Pre Clinical and Clinical Trial in India, V.K.Srinivas, Ph.D, General Manager, R&D, Bharat Biotech International Limited
    • Technology Transfer: Impact and Importance for Indian Biotechnology Growth, Susan Kling Finston, Founder and Principal, Finston Consulting, LLC
    • Outsourcing Biopharma R&D tIndia, Jim Schnabel, Senior Research Associate, BioPlan Associates, Inc.